Clinical News - Page 1

Statins may increase risk diabetes risk: study
Friday, May 24, 2013 Some cholesterol-lowering drugs may put patients at an increased risk of developing type-2 diabetes, according to a new...

Scientists step closer to developing universal influenza jab
Thursday, May 23, 2013 Scientists in the US have edged a step closer to developing a universal vaccine that would protect against multiple strains of influenza without the need for an annual seasonal flu...

Alzheimer’s drug trial coincides with UK’s Dementia Awareness week
Wednesday, May 22, 2013 TauRx Therapeutics has announced that the first of over 100 UK patients have enrolled in the global Phase III clinical trials of its experimental Alzheimer’s drug...

Roche releases positive results for first-of-its-kind leukaemia drug
Thursday, May 16, 2013 A Phase III study into the effectiveness of a first-of-its-kind targeted cancer antibody drug developed by Roche for patients with chronic lymphocytic leukaemia (CLL) and co-existing...

US human cloning breakthrough turns skin cells into embryos
Thursday, May 16, 2013 For the first time ever, scientists in the US have turned human skin cells into early-stage embryos, which were then used to create specialised tissue cells for transplant...

Low-cost Rotavirus vaccine revealed by scientists in India
Wednesday, May 15, 2013 A new vaccine to prevent Rotavirus, which kills around half a million children a year, has been unveiled by scientists in...

Eli Lilly Phase III lymphoma study fails to meet primary endpoint
Tuesday, May 14, 2013 Eli Lilly has announced that its Phase III clinical trial of enzastaurin for the prevention of relapse in patients with diffuse large B-cell lymphoma (DLBCL) has failed, after results did not...

Bacteria makes mosquitoes resistant to malaria: study
Friday, May 10, 2013 Scientists in the US have discovered a strain of bacteria that could prevent the transmission of malaria via mosquitoes to...

Shire signs rare disease discovery deal with Nimbus
Thursday, May 09, 2013 Shire, the UK's third largest pharmaceutical firm, has teamed up with US-based Nimbus Discovery to develop small molecule treatments for rare genetic...

Spider venom vaccine a future possibility due to new research
Thursday, May 09, 2013 Brazilian scientists have created a synthetic protein that could one day lead to a vaccination against poisonous spider...

First H7N9 avian influenza vaccine developed
Thursday, May 02, 2013 Scientists at vaccine manufacturer Greffex say they have created the first comprehensive vaccine for H7N9 avian influenza, one month after the virus was...

Swedish scientists unveil sugar’s transport link to cancer cells
Wednesday, May 01, 2013 Scientists in Sweden have, for the first time, obtained detailed images of the way in which the protein GLUT transports sugars to cells and fuel the rapid growth of...

Clinical trial starts in the UK to heal hearts with genetic virus
Tuesday, April 30, 2013 A group of UK heart failure patients have been enrolled on a new clinical trial to see if a genetically engineered virus can help heal their ailing...

Scientists identify artemisinin-resistant malaria strains in Cambodia
Monday, April 29, 2013 Scientists have pinpointed malaria-causing parasites discovered in western Cambodia that are able to withstand treatment by Chinese drug artemisinin, a frontline drug in the fight against...

Patient cancer treatment could be determined by computer in near future
Tuesday, April 23, 2013 A study carried out by the Maastricht University Medical Hospital in Norway found that a computer was consistently better at predicting future symptoms of patients with lung cancer after...

Impel NeuroPharma completes first ever nose-to-brain delivery study
Friday, April 19, 2013 US based Impel NeuroPharma announced today that it has completed its human proof of concept study with POD technology demonstrating nose-to-brain delivery, opening the door for central...

New sub-type of bowel cancer discovered
Monday, April 15, 2013 A new sub-type of bowel cancer has been discovered that is resistant to some targeted treatment and that is believed to have a worse outcome than other types of colon cancer, say scientists....

Objective way to measure pain discovered
Friday, April 12, 2013 Pain can be objectively measured in patients for the first time ever by examining scans of their brains, according to scientists at the University of Colorado...

US FDA to fast track Pfizer’s breast cancer drug
Thursday, April 11, 2013 Pfizer's investigational compound palbociclib, for the treatment of breast cancer, will be fast tracked for development and review by the US Food and Drug...

Genentech’s experimental cancer drug shows positive results in Phase I study
Wednesday, April 10, 2013 An engineered antibody cancer drug being developed by Genentech, a member of the Roche Group, was found to be safe and effective for several cancers in a Phase I...